Cannabis Prohibition’s Last Stand

By Will Yakowicz

It’s no secret: Most Americans believe cannabis should be legal.

Today, 17 states have legalized adult-use marijuana, meaning more than 40% of Americans now live in a state where marijuana is allowed for those over 21. More than 30 states allow at least some kind of medical marijuana access, which leaves only 2 that have not amended their marijuana laws at all—Idaho and Nebraska.

Senate Majority Leader Chuck Schumer has promised that he and Sens. Cory Booker and Ron Wyden will introduce their cannabis legalization bill, but he hasn’t issued a timeline.

To read more:

MN House passes legal cannabis bill; no future in Senate

By Tim Pugmire

The Minnesota House voted 72-61 Thursday night to legalize cannabis for adult use — a significant step for the legislation. But Minnesota is unlikely to join more than 15 other states in making marijuana legal because majority Republicans in the state Senate will likely prevent it from becoming law this year. 

Under the bill, Minnesotans 21 and older would be allowed to possess up to 2 ounces of cannabis in public and up to 10 pounds in their personal residence.

To read more:

Marijuana Megamerger Would Create a U.S. Cannabis Giant

By Connor Smith

Trulieve Cannabis said it plans to acquire Harvest Health & Recreation in a $2.1 billion all-stock deal. The U.S. cannabis deal would give Florida’s dominant player a notable southwestern U.S. footprint.

Trulieve (ticker: TCNNF) and Harvest Health (HRVSF) combined would be one of the largest cannabis companies in the world, in terms of sales. Combining analyst estimates for both companies puts the estimated 2021 revenue at $1.24 billion, only slightly below consensus estimates for Curaleaf (CURLF) at $1.26 billion. Trulieve would also be the most profitable, notes CEO Kim Rivers, pointing to consensus estimates for combined 2021 adjusted earnings before interest, taxes, depreciation, and amortization, or Ebitda, of $461 million.

To read more:

Will cannabis legalization reduce crime in Mexico? Has it in the US?

By Vanda Felbab-Brown

Soon, Mexico will likely become the world’s third country to legalize all aspects of cannabis production and all types of the plant’s use. In a series of columns, I explored whether the legalization was likely to deliver the promised advancement in civil liberties in Mexico and generate high tax revenues and legal incomes for farmers of illicit crops, also the negative environmental impacts of cannabis cultivation, including water depletion. In this column, I will examine whether cannabis legalization is likely to eliminate the black market, deprive violent criminal groups of money, and reduce criminal violence.

To read more:

Thailand’s ‘father’ of cannabis wants small-time growers to be part of medical marijuana industry

ByJitsiree Thongnoi

When Aram Limsakul’s son and daughter came down with dengue fever two years ago, he gave the children, then aged five and four, a vaporiser to inhale the smoke from his own home-grown marijuana.

Within a few days, “their fever reduced, they stopped vomiting and ate for the first time in days”, he said.One of Thailand’s most prominent marijuana advocates, Aram grew up with cannabis in his backyard in the south of the country, and has been growing the plant since 1991. People far and wide have for decades been seeking his advice on using cannabis for a range of ailments.

To read more:

Canopy Growth to acquire Supreme Cannabis in latest tie-up in busy weed sector

By Ciara Linnane

Canopy Growth Corp. said Thursday it has reached an agreement to acquire Toronto-based Supreme Cannabis Co. Inc. in the latest M&A deal in a cannabis sector that is seeing a burst of activity amid hopes for reform of strict U.S. laws.

Canopy CGC CA:WEED said the stock-and-cash deal is valued at about C$435 million ($345.6 million). Supreme Cannabis SPRWF CA:FIRE shareholders will receive 0.01165872 of Canopy stock for each share owned, plus C$0.0001 in cash. That is equal to a premium of about 66% for Supreme Cannabis shareholders based on the closing prices of both stocks on the Toronto Stock Exchange on Wednesday.

To read more:

CBD, marijuana and hemp: What is the difference among these cannabis products, and which are legal?

By Brandon McFadden

New York recently became the 15th U.S. state to legalize cannabis for recreational use.

While 67% of U.S. adults support marijuana legalization, public knowledge about cannabis is low. A third of Americans think hemp and marijuana are the same thing, according to the National Institutes of Health, and many people still search Google to find out whether cannabidiol – a cannabis derivative known as CBD – will get them high, as marijuana does.

To read more:

Clinical Management of Cannabis Complications

By Psychiatric Times

The first piece highlights the use of cannabinoids among the geriatric population. Cannabis and cannabidiol (CBD) use in older adults has become more prevalent as a result of reduced stigma; leniency in state restrictions on possession and sale; and advertisements touting benefits for chronic pain, peripheral neuropathy, stress, anxiety, depression, insomnia, headaches, and the adverse effects of chemotherapy. Medical marijuana use by individuals 65 and older has increased more than 8-fold in recent years. The article nicely summarizes how heavy marijuana use can cause mild functional and structural brain impairments, affecting attention, processing speed, motor coordination, verbal memory, and executive function.

To read more: